Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

LoBue PA, Mermin JH.

Lancet Infect Dis. 2017 May 8. pii: S1473-3099(17)30248-7. doi: 10.1016/S1473-3099(17)30248-7. [Epub ahead of print] Review.

PMID:
28495525
2.

Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.

Sweeney P, Gray SC, Purcell DW, Sewell J, Babu AS, Tarver BA, Prejean J, Mermin J.

AIDS. 2017 Jun 19;31(10):1483-1488. doi: 10.1097/QAD.0000000000001501.

PMID:
28398957
3.

Sustained Reduction in HIV Diagnoses in Massachusetts, 2000-2014.

Cranston K, John B, Fukuda HD, Randall LM, Mermin J, Mayer KH, DeMaria A Jr.

Am J Public Health. 2017 May;107(5):794-799. doi: 10.2105/AJPH.2017.303697.

PMID:
28398778
4.

Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.

Granich R, Gupta S, Hall I, Aberle-Grasse J, Hader S, Mermin J.

PLoS Med. 2017 Apr 4;14(4):e1002253. doi: 10.1371/journal.pmed.1002253. eCollection 2017 Apr. Review.

5.

Lifetime risk of a diagnosis of HIV infection in the United States.

Hess KL, Hu X, Lansky A, Mermin J, Hall HI.

Ann Epidemiol. 2017 Apr;27(4):238-243. doi: 10.1016/j.annepidem.2017.02.003. Epub 2017 Feb 21.

PMID:
28325538
6.

HIV Trends in the United States: Diagnoses and Estimated Incidence.

Hall HI, Song R, Tang T, An Q, Prejean J, Dietz P, Hernandez AL, Green T, Harris N, McCray E, Mermin J.

JMIR Public Health Surveill. 2017 Feb 3;3(1):e8. doi: 10.2196/publichealth.7051.

7.

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, Bohm MK, Jones CM, Flanagan BE, Siddiqi AE, Iqbal K, Dent AL, Mermin JH, McCray E, Ward JW, Brooks JT.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331.

PMID:
27763996
8.

Koenig et al. Respond.

Koenig LJ, Purcell DW, Zaza S, Mermin J.

Am J Public Health. 2016 Oct;106(10):e3. doi: 10.2105/AJPH.2016.303340. No abstract available.

PMID:
27626356
9.

HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, Blosser SJ, Spiller MW, Combs B, Switzer WM, Conrad C, Gentry J, Khudyakov Y, Waterhouse D, Owen SM, Chapman E, Roseberry JC, McCants V, Weidle PJ, Broz D, Samandari T, Mermin J, Walthall J, Brooks JT, Duwve JM; Indiana HIV Outbreak Investigation Team.

N Engl J Med. 2016 Jul 21;375(3):229-39. doi: 10.1056/NEJMoa1515195.

10.

The Importance of Population Denominators for High-Impact Public Health for Marginalized Populations.

Purcell DW, Hall HI, Bernstein KL, Gift TL, McCray E, Mermin J.

JMIR Public Health Surveill. 2016 May 17;2(1):e26. doi: 10.2196/publichealth.5883. No abstract available.

11.

Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey.

Kim AA, Parekh BS, Umuro M, Galgalo T, Bunnell R, Makokha E, Dobbs T, Murithi P, Muraguri N, De Cock KM, Mermin J; 2007 KAIS study group.

PLoS One. 2016 May 19;11(5):e0155498. doi: 10.1371/journal.pone.0155498. eCollection 2016.

12.

Cost Effectiveness of HIV Prevention Interventions in the U.S.

Lin F, Farnham PG, Shrestha RK, Mermin J, Sansom SL.

Am J Prev Med. 2016 Jun;50(6):699-708. doi: 10.1016/j.amepre.2016.01.011. Epub 2016 Mar 2.

PMID:
26947213
13.

Current and (Potential) Future Effects of the Affordable Care Act on HIV Prevention.

Viall AH, McCray E, Mermin J, Wortley P.

Curr HIV/AIDS Rep. 2016 Apr;13(2):95-106. doi: 10.1007/s11904-016-0306-z. Review.

PMID:
26894486
14.

Shifting Resources and Focus to Meet the Goals of the National HIV/AIDS Strategy: The Enhanced Comprehensive HIV Prevention Planning Project, 2010-2013.

Flores SA, Purcell DW, Fisher HH, Belcher L, Carey JW, Courtenay-Quirk C, Dunbar E, Eke AN, Galindo CA, Glassman M, Margolis AD, Neumann MS, Prather C, Stratford D, Taylor RD, Mermin J; ECHPP Project Team.

Public Health Rep. 2016 Jan-Feb;131(1):52-8.

15.

The Shift to High-Impact HIV Prevention by Health Departments in the United States.

Purcell DW, McCray E, Mermin J.

Public Health Rep. 2016 Jan-Feb;131(1):7-10. No abstract available.

16.

Young People and HIV: A Call to Action.

Koenig LJ, Hoyer D, Purcell DW, Zaza S, Mermin J.

Am J Public Health. 2016 Mar;106(3):402-5. doi: 10.2105/AJPH.2015.302979. Epub 2016 Jan 21.

PMID:
26794156
17.

Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D.

MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1337-41. doi: 10.15585/mmwr.mm6448a3.

18.

Applying Public Health Principles to the HIV Epidemic--How Are We Doing?

Frieden TR, Foti KE, Mermin J.

N Engl J Med. 2015 Dec 3;373(23):2281-7. doi: 10.1056/NEJMms1513641. Epub 2015 Dec 1. No abstract available.

19.

Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.

Ward JW, Mermin JH.

N Engl J Med. 2015 Dec 31;373(27):2678-80. doi: 10.1056/NEJMe1513245. Epub 2015 Nov 17. No abstract available.

20.

Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.

Hutchinson AB, Farnham PG, Sansom SL, Yaylali E, Mermin JH.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):323-30. doi: 10.1097/QAI.0000000000000838.

Supplemental Content

Loading ...
Support Center